177 related articles for article (PubMed ID: 38469235)
1. Multidisciplinary approach and treatment of acral and mucosal melanoma.
Fortuna A; Amaral T
Front Oncol; 2024; 14():1340408. PubMed ID: 38469235
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapy and Immunotherapy for Melanoma in Japan.
Namikawa K; Yamazaki N
Curr Treat Options Oncol; 2019 Jan; 20(1):7. PubMed ID: 30675668
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
Mao L; Qi Z; Zhang L; Guo J; Si L
Front Immunol; 2021; 12():680407. PubMed ID: 34149718
[TBL] [Abstract][Full Text] [Related]
4. KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
Yun J; Lee J; Jang J; Lee EJ; Jang KT; Kim JH; Kim KM
APMIS; 2011 Jun; 119(6):330-5. PubMed ID: 21569090
[TBL] [Abstract][Full Text] [Related]
5. Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.
Zou Z; Ou Q; Ren Y; Lv Q; Qin L; Zhao L; Su S; Wu X; Bao H; Wang A; Zhu D; Wang X; Shao YW; Liu B
Pigment Cell Melanoma Res; 2020 Jul; 33(4):601-611. PubMed ID: 31944535
[TBL] [Abstract][Full Text] [Related]
6. Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.
Jung S; Johnson DB
Oncologist; 2022 Aug; 27(8):703-710. PubMed ID: 35640549
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma.
Lian B; Li Z; Wu N; Li M; Chen X; Zheng H; Gao M; Wang D; Sheng X; Tian H; Si L; Chi Z; Wang X; Lai Y; Sun T; Zhang Q; Kong Y; Long GV; Guo J; Cui C
Ann Oncol; 2024 Feb; 35(2):211-220. PubMed ID: 37956739
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
Kirkwood JM; Del Vecchio M; Weber J; Hoeller C; Grob JJ; Mohr P; Loquai C; Dutriaux C; Chiarion-Sileni V; Mackiewicz J; Rutkowski P; Arenberger P; Quereux G; Meniawy TM; Ascierto PA; Menzies AM; Durani P; Lobo M; Campigotto F; Gastman B; Long GV
Nat Med; 2023 Nov; 29(11):2835-2843. PubMed ID: 37845511
[TBL] [Abstract][Full Text] [Related]
9. New Approaches to Targeted Therapy in Melanoma.
Fernandez MF; Choi J; Sosman J
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370834
[TBL] [Abstract][Full Text] [Related]
10. Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma.
Stoff R; Asher N; Laks S; Steinberg Y; Schachter J; Shapira-Frommer R; Grynberg S; Ben-Betzalel G
Front Oncol; 2023; 13():1180988. PubMed ID: 37274272
[TBL] [Abstract][Full Text] [Related]
11. Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in
de Braud F; Dooms C; Heist RS; Lebbe C; Wermke M; Gazzah A; Schadendorf D; Rutkowski P; Wolf J; Ascierto PA; Gil-Bazo I; Kato S; Wolodarski M; McKean M; Muñoz Couselo E; Sebastian M; Santoro A; Cooke V; Manganelli L; Wan K; Gaur A; Kim J; Caponigro G; Couillebault XM; Evans H; Campbell CD; Basu S; Moschetta M; Daud A
J Clin Oncol; 2023 May; 41(14):2651-2660. PubMed ID: 36947734
[TBL] [Abstract][Full Text] [Related]
12. Objective response to immune checkpoint inhibitor therapy in
Jaeger ZJ; Raval NS; Maverakis NKA; Chen DY; Ansstas G; Hardi A; Cornelius LA
Front Med (Lausanne); 2023; 10():1090737. PubMed ID: 36873887
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
Patel SP; Othus M; Chen Y; Wright GP; Yost KJ; Hyngstrom JR; Hu-Lieskovan S; Lao CD; Fecher LA; Truong TG; Eisenstein JL; Chandra S; Sosman JA; Kendra KL; Wu RC; Devoe CE; Deutsch GB; Hegde A; Khalil M; Mangla A; Reese AM; Ross MI; Poklepovic AS; Phan GQ; Onitilo AA; Yasar DG; Powers BC; Doolittle GC; In GK; Kokot N; Gibney GT; Atkins MB; Shaheen M; Warneke JA; Ikeguchi A; Najera JE; Chmielowski B; Crompton JG; Floyd JD; Hsueh E; Margolin KA; Chow WA; Grossmann KF; Dietrich E; Prieto VG; Lowe MC; Buchbinder EI; Kirkwood JM; Korde L; Moon J; Sharon E; Sondak VK; Ribas A
N Engl J Med; 2023 Mar; 388(9):813-823. PubMed ID: 36856617
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]